Physical Disability in Patients Treated With Betaferon
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
To gather Observation data about physical disability progression, safety and adherence during
the use of Betaferon in daily practice. Patients with any type of Multiple Sclerosis (MS)
(MRRS) (PSMS), under treatment with Betaferon.Open Multicentric Observational study.24
months.Evaluation of physical disability in patients treated with Betaferon, using Kurtzke's
expanded disability scale (EDSS) in biannual periods